Trials / Unknown
UnknownNCT04912349
Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume
Comparison of Transurethral Split of the Prostate Versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume: A Prospective Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- Male
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of transurethral split of the prostate versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia in a small prostate volume: A prospective controlled study
Detailed description
Transurethral resection of the prostate (TURP) was considered as the golden standard to treat benign prostatic hyperplasia (BPH) for decades. However, TURP was associated with low efficiency to alleviate the lower urinary tract symptoms and a significantly higher risk of bladder neck contracture (BNC) for patients with small-volume BPH. We aimed to compare the therapeutic effect of transurethral split of the prostate (TUSP) with TURP for patients with small-volume BPH (\<30 ml). In this study, some selected small-volume BPH patients were randomly divided into two groups (TUSP and TURP group). The patient's baseline characteristics and perioperative outcomes were recorded. The follow-up was made at 6 months, 1 year and 2 years after surgical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TUSP | Patients received the transurethral split of the prostate(TUSP) treatment. |
| PROCEDURE | TURP | Patients received the transurethral resection of the prostate(TURP) treatment. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2021-06-03
- Last updated
- 2021-06-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04912349. Inclusion in this directory is not an endorsement.